Condition
Trastuzumab Deruxtecan clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Trastuzumab Deruxtecan clinical trials that are recruiting, at sites in 2 countries (most in Russia (1), South Korea (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Trastuzumab deruxtecan for Russian patients with HER2-positive unresectable or metastatic breast cancer
This study will see how well trastuzumab deruxtecan (T-DXd) works in Russian adults with unresectable or metastatic HER2-positive breast cancer who received at least one cycle.
-
Using Trastuzumab Emtansine after Trastuzumab Deruxtecan for HER2-Positive Breast Cancer
This study is testing if giving trastuzumab emtansine right after trastuzumab deruxtecan helps people with advanced HER2-positive breast cancer who haven't responded to the first treatment.
Related topics
Quick answers
How many Trastuzumab Deruxtecan clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Russia (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.